Michael Churchill,
Lead Scientist
I build new tools and novel platforms to innovate and optimize high throughput screening technologies. I began working at SEngine Precision Medicine in the Fall of 2016 and have since applied my knowledge and expertise of high-throughput and high-content screen design to maintain and innovate the SEngine clinical platform and to ensure that SEngine remains an industry pioneer during an era of unprecedented innovation of healthcare and biotechnology. On my watch, I will assure that SEngine and the PARIS test evolve faster than cancer.
|
|
|
